Funding This work was supported by the National Natural Science Foundation of China (82370383), Guangdong Natural Science Foundation (2024A1515013289), Jiangxi Provincial Health Commission Science and Technology Plan Project (202310008), and Jiangxi Natural Science Foundation (20232BAB206055)
doi: 10.7150/thno.51154 102 CastaldoGPaganoIGrimaldiMMarinoCMolettieriPSantoroAet al
Tirzepatide is FDA-approved under two brand names: Mounjaro (type 2 diabetes, approved May 2022) and Zepbound (chronic weight management, approved November 2023)
The program will operate outside of Part Ds benefit and payment structure
We're not going to talk about that today, but what makes this topic fascinating is how a natural sugar might actually help control blood sugar and appetite rather than spike it, although, again, we're not going to fear monger over spikes in blood sugar